Pfizer Inc.‘s ousted CEO Jeffrey Kindler will receive about $9.6 million in severance, bonus, and short term incentive pay for 2010, according to a severance package made public late Thursday.

Kindler, who was promoted from general counsel to chairman and chief executive officer of the drug giant four years ago, also is entitled to retirement pay, stock holdings, and other benefits. The severance package, agreed to only hours before Pfizer’s board of directors met last Sunday and accepted Kindler’s resignation, was surprisingly small.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]